L. K. Griffeth, Use of PET/CT scanning in cancer patients: technical and practical considerations, Proc. (Bayl. Univ. Med. Cent)., 2005, 18, 321-330.Griffeth LK: Use of PET/CT scanning in cancer patients: technical and practical considerations. Proc (Bayl Univ Med Cent) 2005, 18:...
Since the turn of the millennium we are now using PET scans (which tag radioactiveglucose metabolism) to evaluate the spread and activity ofcancer. PET scans are more sensitive than other tests in evaluating cancer patients for many forms of cancer. ...
PET scans had been performed for 3.60% of patients with bladder cancer, 1.09% of those with prostate cancer, and 5.32% of those with RCC. On regression analysis, a more recent year of diagnosis, younger age, and high stage or grade were predictors of PET scan usage for patients with ...
1. Zhang YQ, Hu PC, Wu RZ, Gu YS, Chen SG, Yu HJ, Wang XQ, Song J, Shi HC. The image quality, lesion detectability, and acquisition time of18F-FDG total-body PET/CT in oncological patients. Eur J Nucl M...
(2020)The International Journal of Cardiovascular Imaging.6.Recognizing tumor origin for lymphoid tumor of unknown primary via total-body PET/CT scan --- Case Report.(2022)Front Oncol.7.Metabolic and Textural Changes i...
PET yields high PPV for recurrent CRC, particularly for liver metastases, in spite of normal CEA levels and should be considered early in the evaluation of patients with suspected tumor recurrence.Background Colorectal cancer (CRC) is the third most common cause of cancer in both men and in wo...
Lung CancerAim: There is very few data about the use of positron emission tomography [PET] in the long term follow up of patients operated for lung cancer. We aimed to evaluate the effectiveness of PET scan in detecting distant metastases in the long term follow up of asymptomatic patients ...
world journal of surgical oncology fdg-pet scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal cea I Sarikaya,M Bloomston,SP Povoski,... 被引量: 0发表: 2017年 In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal ...
Results of a PSMA PET scan may help physicians and patients decide between radiotherapy and systemic therapy. To determine eligibility for lutetium Lu-177 vipivotide tetraxetan (Lu-177 PSMA), a radiopharmaceutical treatment that targets PSMA-expressing prostate cancer. This treatment can be used in ...
Prognostic value of [[sup 18] F]FDG-PET imaging in small cell lung cancer. In the eight untreated patients, scans were strongly positive and in all cases the scan results concurred with the final clinical stage assigned on the ... Pandit,Neeta,Gonen,... - 《European Journal of Nuclear ...